ABVC BioPharma Inc. (ABVC)
NASDAQ · Healthcare
ABVC BioPharma Inc. Shareholder Equity 2010–2025
ABVC BioPharma Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- ABVC BioPharma Inc. shareholder equity as of December 31, 2025: 11.1M, a 806.25% increase year-over-year.
- ABVC BioPharma Inc. shareholder equity for 2025 were 11.1M, a 806.25% increase from 2024.
- ABVC BioPharma Inc. shareholder equity for 2024 were 1.2M, a 21.10% decrease from 2023.
- ABVC BioPharma Inc. shareholder equity for 2023 were 1.6M, a 49.84% decrease from 2022.
- ABVC BioPharma Inc. shareholder equity for 2022 were 3.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| ABVC BioPharma Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $11 |
| 2024 | $1 |
| 2023 | $2 |
| 2022 | $3 |
| 2021 | $9 |
| 2020 | $3 |
| 2019 | $-0 |
| 2018 | $-6 |
| 2015 | $0 |
| 2013 | $0 |
| 2012 | $-2 |
| 2011 | $-1 |
| 2010 | $-3 |
ABVC BioPharma Inc. Shareholder Equity — FAQ
ABVC BioPharma Inc. (ABVC) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABVC's shareholder equity history?
The chart and table above show ABVC BioPharma Inc.'s shareholder equity by year and by quarter, including the growth rate.